Skip to main content
TipRanks
Go Ultimate75% OFF

Immunicum AB (IMMU) Income Statement

3 Followers

Immunicum AB Income Statement

Last quarter (Q3 2026), Immunicum AB's total revenue was kr0.00. In Q3, Immunicum AB's net income was kr-22.68M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 0.00kr 0.00kr 28.49Mkr 3.00Mkr 6.00K
kr -6.29Mkr -6.52Mkr 28.49Mkr -1.85Mkr -1.84M
kr 113.49Mkr 128.63Mkr 123.40Mkr 134.70Mkr 129.28M
Depreciation and Amortizationkr 6.29Mkr 6.50Mkr 6.29Mkr 4.85Mkr 1.85M
kr -113.97Mkr -120.68Mkr -94.92Mkr -128.67Mkr -128.28M
kr -120.26Mkr -135.15Mkr -100.65Mkr -133.68Mkr -130.10M
kr 7.00Mkr 6.75Mkr -969.00Kkr -5.10Mkr -3.31M
kr -113.26Mkr -128.40Mkr -101.62Mkr -138.78Mkr -133.41M
kr -113.26Mkr -128.40Mkr -101.62Mkr -136.99Mkr -136.69M
Per Share Metrics
Basic EPSkr -2.17kr -2.64kr -4.40kr -0.63kr -0.68
Diluted EPSkr -2.17kr -2.64kr -4.39kr -0.63kr -0.68
Weighted Average Shares Outstanding52.19M48.64M23.10M216.49M199.75M
Weighted Average Shares Outstanding (Diluted)52.19M48.64M23.13M216.49M199.75M

Currency in SEK

Immunicum AB Earnings and Revenue History

-160M-80M080M-2400000 %-1600000 %-800000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin